RxDoctor Payments Data

Trista Hewett, NP

Family · Columbia, SCNPI 1417410572

Payments from drug & device makers

$1,112in general payments, 2019–2025

Across 61 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$298
  • Novo Nordisk$157
  • Lilly USA, LLC$154
  • Pfizer$111
  • AbbVie$99
  • Exact Sciences$70
  • plus $222 from 8 others

What the payments were for

  • Food & beverage$1,112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,112 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$98,689
Medicare patients
235
Services billed
2,708

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide105$135,548
OzempicSemaglutide51$65,899
FarxigaDapagliflozin Propanediol50$60,149
JardianceEmpagliflozin17$26,699
EliquisApixaban26$24,630
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$12,539
Humalog Kwikpen U-100Insulin Lispro13$5,137
Lantus SolostarInsulin Glargine,hum.Rec.Anlog44$4,479
Ezetimibe40$3,025
Levothyroxine Sodium209$2,698
Rosuvastatin Calcium150$2,467
Atorvastatin Calcium202$2,442
Omeprazole143$2,164
Famotidine94$1,843
Nano 2nd Gen Pen NeedlePen Needle, Diabetic11$1,671

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$154$135,548105 claims
Novo NordiskOzempic$157$65,89951 claims
AstraZenecaFarxiga$298$60,14950 claims
PfizerEliquis$111$24,63026 claims
GSKTrelegy Ellipta$16$12,53916 claims
AbbVieSynthroid$99$97017 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.

Other family in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →